|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
Imaging Diagnostic Systems, Inc. Imaging Diagnostic Systems Renews Its Distribution Agreement with EDO-MED
Imaging Diagnostic Systems, Inc. Imaging Diagnostic Systems Renews Its Distribution Agreement with EDO-MED
Imaging Diagnostic Systems Renews Its Distribution Agreement with EDO-MED
Friday, 17 April 2009 04:59 | 
| Company News - Imaging Diagnostic Systems, Inc. |
Imaging Diagnostic Systems, Inc. announced that it has renewed its distribution agreement with EDO-MED Sp. Z.o.o. as the exclusive distributor in Poland
EDO MED will continue to market and provide technical service support for the CT Laser Mammography ( CTLM (R)) system throughout Poland, as well as to assist with and promote the ongoing research efforts utilizing CTLM technology at the Comprehensive Cancer Centre in Gliwice, Poland, and other institutes and research centers.
IDSI will continue to collaborate with EDO MED to develop the CTLM clinical research program in Poland, providing support for hospitals using the system as part of their routine practice and research to further investigate additional usage of the system. The Company will also provide assistance for EDO MED's sales and marketing initiatives.
"Poland continues to seek methods that can improve breast cancer detection," commented Jaroslaw Borkulak, EDO MED President. "EDO MED is a well established company in the functional imaging and oncology market, and CTLM technology complements our product base of innovative, well-established products. EDO MED is pleased to continue our business relationship with IDSI, as we see great potential for the CTLM system for women, both in Poland and internationally."
In Poland, the CTLM system is currently used at the Comprehensive Cancer Center, Maria Sklodowska-Curie Memorial Institute, and the Military Institute of Health Services in Gliwice and Warsaw.
About Imaging Diagnostic Systems, Inc.
Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM (R) system is a patented new breast imaging system that utilizes continuous wave laser technology and patented algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. For more information, visit corporate website: www.imds.com
Source: Imaging Diagnostic Systems
IDSI will continue to collaborate with EDO MED to develop the CTLM clinical research program in Poland, providing support for hospitals using the system as part of their routine practice and research to further investigate additional usage of the system. The Company will also provide assistance for EDO MED's sales and marketing initiatives.
"Poland continues to seek methods that can improve breast cancer detection," commented Jaroslaw Borkulak, EDO MED President. "EDO MED is a well established company in the functional imaging and oncology market, and CTLM technology complements our product base of innovative, well-established products. EDO MED is pleased to continue our business relationship with IDSI, as we see great potential for the CTLM system for women, both in Poland and internationally."
In Poland, the CTLM system is currently used at the Comprehensive Cancer Center, Maria Sklodowska-Curie Memorial Institute, and the Military Institute of Health Services in Gliwice and Warsaw.
About Imaging Diagnostic Systems, Inc.
Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM (R) system is a patented new breast imaging system that utilizes continuous wave laser technology and patented algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. For more information, visit corporate website: www.imds.com
Source: Imaging Diagnostic Systems
